Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Can Agoracom message boards be used as a rallying point for shareholders?

As such, AGORACOM derives more than 95% of revenues from public companies that engage us via annual contracts to utilize our superior Web 2.0 community and communications tools. We declare every client via press release and clearly label ourselves as their “official online IR firm” throughout the site.

We believe in small entrepreneurs and small investors. We serve them by widely disseminating great information and then providing current and prospective investors with unsurpassed management access to conduct the best due diligence possible, leading to the most informed investment decision possible.

http://agoracom.com/about-and-contact

Perhaps PTSC falls in the 5% category and as such Agora does not derive revenues from PTSC.

Share
New Message
Please login to post a reply